[go: up one dir, main page]

WO2002032929A3 - Haplotypes du gene cer1 - Google Patents

Haplotypes du gene cer1 Download PDF

Info

Publication number
WO2002032929A3
WO2002032929A3 PCT/US2001/046100 US0146100W WO0232929A3 WO 2002032929 A3 WO2002032929 A3 WO 2002032929A3 US 0146100 W US0146100 W US 0146100W WO 0232929 A3 WO0232929 A3 WO 0232929A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
cer1
gene
disclosed
cer1 gene
Prior art date
Application number
PCT/US2001/046100
Other languages
English (en)
Other versions
WO2002032929A2 (fr
Inventor
Amir Kazemi
Nisha Shah
Original Assignee
Genaissance Pharmaceuticals
Amir Kazemi
Nisha Shah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Amir Kazemi, Nisha Shah filed Critical Genaissance Pharmaceuticals
Priority to AU2002227172A priority Critical patent/AU2002227172A1/en
Publication of WO2002032929A2 publication Critical patent/WO2002032929A2/fr
Publication of WO2002032929A3 publication Critical patent/WO2002032929A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouvelles variantes génétiques du gène « Cerberus 1 (Xenopus Laevis) Homologue (Cysteine Knot Superfamily) » (CER1). Par ailleurs, l'invention concerne divers génotypes, haplotypes, et paires d'haplotypes du gène CER1 présent dans la population générale des Etats-Unis. De plus, l'invention concerne des compositions et des méthodes d'haplotypage et/ou de génotypage du gène CER1 chez un individu, ainsi que des polynucléotides définis par la séquence des haplotypes selon l'invention.
PCT/US2001/046100 2000-10-19 2001-10-19 Haplotypes du gene cer1 WO2002032929A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002227172A AU2002227172A1 (en) 2000-10-19 2001-10-19 Haplotypes of the cer1 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24163400P 2000-10-19 2000-10-19
US60/241,634 2000-10-19

Publications (2)

Publication Number Publication Date
WO2002032929A2 WO2002032929A2 (fr) 2002-04-25
WO2002032929A3 true WO2002032929A3 (fr) 2003-09-18

Family

ID=22911516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/046100 WO2002032929A2 (fr) 2000-10-19 2001-10-19 Haplotypes du gene cer1

Country Status (2)

Country Link
AU (1) AU2002227172A1 (fr)
WO (1) WO2002032929A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US9045553B2 (en) 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
EP1755648A2 (fr) 2004-05-27 2007-02-28 Acceleron Pharma Inc. Derives de cerberus/coco et leurs applications
EP2099471A2 (fr) 2006-12-08 2009-09-16 Acceleron Pharma, Inc. Utilisations de cerberus, de coco et de leurs dérivés
US20110184044A1 (en) * 2008-05-12 2011-07-28 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
CN108823220B (zh) * 2018-07-25 2021-07-20 山东农业大学 一种苹果中蜡质合成相关基因MdCER1的克隆及其应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] LAH ET AL.: "Human cerberus related gene CER1 maps to chromosome 9", XP002962767, retrieved from GI:4406153 accession no. NCBI Database accession no. (AF090189) *
GENOMICS, vol. 55, no. 3, 12 March 1999 (1999-03-12), pages 364 - 366 *
LAH ET AL.: "Human cerberus related gene CER1 maps to chromosome 9", GENOMICS, vol. 55, 1999, pages 364 - 366, XP002962766 *

Also Published As

Publication number Publication date
WO2002032929A2 (fr) 2002-04-25
AU2002227172A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
WO2002032929A3 (fr) Haplotypes du gene cer1
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001079228A3 (fr) Haplotypes du gene f12
WO2002006446A3 (fr) Haplotypes du gene edg6
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002055534A3 (fr) Haplotypes du gene f2rli
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002044201A3 (fr) Haplotypes du gene sah
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2001075065A3 (fr) Haplotypes du gene gp1ba
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2002022650A3 (fr) Haplotypes du gene per1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP